0 avis
The MYCN oncoprotein and helicases DDX17 and DDX5 have opposite effects on the production of chimeric transcripts in neuroblastoma cells
Archive ouverte
Edité par CCSD -
DEAD box helicases DDX17 and DDX5 control transcription termination and the associated processing of the 3' end of transcripts. Here we show that the transcriptional readthrough induced by their depletion in neuroblastoma cells results in increased production of chimeric transcripts from tandemly orientated genes. Analysis of neuroblastoma tumours in which chimeric transcripts are abundant revealed that low expression of DDX17 and DDX5 genes is associated with high-risk tumours and poor overall patient survival, and inversely linked with MYCN oncogene amplification. We demonstrate that changes in MYCN expression do not affect the expression of either helicase, but alter transcription termination leading to the production of chimeric transcripts. MYCN acts on termination through its direct binding to the 3' region of genes and it interacts with DDX17, suggesting that it may inhibit the activity of the helicase. Collectively, our work reveals a novel function of MYCN in transcription termination and suggests that the deregulation of MYCN and DDX17/DDX5 expression in neuroblastoma may lead to the expression of non-canonical and potentially harmful RNA molecules.